Piper Sandler analyst Brent Bracelin maintains Microsoft (NASDAQ:MSFT) with a Overweight and raises the price target from $247 to $290.
HeartBeam Announces Automated Cardiac Detection Patent Granted For HeartBeam AIMIGo System
Patent Underscores AI for Vectorcardiography (VECG) IP Leadership Effort
HeartBeam, Inc. (NASDAQ:BEAT), a cardiac technology company that has developed the first and only 3D vector electrocardiogram (VECG) platform